The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.

The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study.
复制标题

DOI:
10.1016/j.jdiacomp.2020.107748
复制
发表时间:
2020-12
影响因子:
3
通讯作者:
Hessler D
Hessler D
中科院分区:
医学3区
文献类型:
--
作者:
Fisher L;Polonsky W;Asuni A;Jolly Y;Hessler D

文献摘要

参考文献

被引文献

相似文献

为了描述COVID-19大流行对美国T1 D或T2 D成人患者的影响,从“控制你的糖尿病研究注册中心”招募的参与者年龄≥19岁,诊断为T1 D或T2 D ≥12个月。参与者在一个受HIPAA保护的平台上完成了一项在线调查。从763名T1 D和619名T2 D中收到了已完成的调查。平均T1 D年龄为53.3岁(SD = 15.3);平均T2 D年龄为64.9岁(SD = 10.3)。这两个样本主要是女性,非西班牙裔白色和受过良好教育。T1 D患者自我报告的平均HbA 1c为6.9(SD = 1.0; 52 mmol/mol),T2 D患者为7.1(SD = 1.1; 54 mmol/mol)。大约40%的受访者报告说,他们当时的所有糖尿病医疗预约都被取消或推迟,40%的受访者报告说,他们转向了远程医疗预约,近一半的受访者报告说,他们对这些就诊的总体满意度较低(与大流行前相比)。一般和与糖尿病有关的压力和社会孤立普遍增加,对疾病管理产生负面影响。两组中约25%的人报告了高、低和葡萄糖变异性的增加。由于这一大流行病,与糖尿病有关的一般生活压力和社会孤立程度大幅增加,对疾病管理产生了重大影响。我们发现,与大流行前相比,糖尿病相关的和一般的生活压力以及社会隔离增加。我们发现,与大流行前的状态相比,饮食/运动发生了变化,血糖升高/降低更多,血糖变异性更大。我们发现,与大流行前的水平相比,远程医疗的使用增加,但总体满意度较低。
To describe the effects of the COVID-19 pandemic on adults with T1D or T2D in the U.S. Participants, recruited from the Taking Control of Your Diabetes Research Registry, were ≥19 years old and diagnosed with either T1D or T2D for ≥12 months. Participants completed an online survey on a HIPAA-protected platform. Completed surveys were received from 763 T1Ds and 619 T2Ds. Average T1D age was 53.3 (SD = 15.3); average T2D age was 64.9 (SD = 10.3). Both samples were predominantly female, non-Hispanic white and well-educated. Average self-reported HbA1c was 6.9 (SD = 1.0; 52 mmol/mol) for T1Ds and 7.1 (SD = 1.1; 54 mmol/mol) for T2Ds. About 40% of respondents reported that all of their diabetes healthcare appointments at the time were cancelled or postponed, 40% reported a switch to telehealth appointments and almost half reported lower overall satisfaction with these visits (compared to pre-pandemic). There were widespread increases in general and diabetes-related stress and social isolation, and negative effects on disease management. About 25% reported increases in highs, lows, and glucose variability in both groups. There has been a substantive increase in level of diabetes-related and general life stress and social isolation due to the pandemic, with a significant impact on disease management. We find a increases in diabetes-related and general life stress, and social isolation, compared to pre-pandemic status. We find changes in diet/exercise, more highs/lows, and greater glucose variability, compared to pre-pandemic status. We find increased use of telemedicine with lower overall satisfaction, compared to pre-pandemic levels.
DOI: 10.1016/j.pec.2010.10.030
发表时间: 2011-11
影响因子: 3.5
作者:
Hessler DM;Fisher L;Mullan JT;Glasgow RE;Masharani U
通讯作者: Masharani U
DOI: 10.1093/abm/kaaa049
发表时间: 2020-08-01
影响因子: 3.8
作者:
Bourassa, Kyle J.;Sbarra, David A.;Moffitt, Terrie E.
通讯作者: Moffitt, Terrie E.
DOI: 10.1111/dme.14319
发表时间: 2020-05-29
期刊: DIABETIC MEDICINE
影响因子: 3.5
作者:
Joensen, L. E.;Madsen, K. P.;Willaing, I.
通讯作者: Willaing, I.
DOI: 10.1111/dme.12241
发表时间: 2013-09-01
期刊: DIABETIC MEDICINE
影响因子: 3.5
作者:
Joensen, L. E.;Tapager, I.;Willaing, I.
通讯作者: Willaing, I.
DOI: 10.3390/ijerph17051729
发表时间: 2020-03-01
影响因子: --
作者:
Wang, Cuiyan;Pan, Riyu;Ho, Roger C.
通讯作者: Ho, Roger C.